Neuroscience
Parkinson's Disease
100%
Artificial Neural Network
75%
Brain Ischemia
64%
Diabetes Mellitus
24%
Cognitive Disorders
20%
Cognitive Function
18%
Neurofilament Light Chain
18%
Amyloid
18%
Tissue Plasminogen Activator
17%
Magnetic Resonance Imaging
15%
Body Mass Index
14%
Hemoglobin A1c
11%
Synuclein
11%
Decision-Making
11%
Behavior (Neuroscience)
9%
Insulin-Like Growth Factor 1
9%
Retinal Disease
9%
Neuroscience
9%
Brain-Derived Neurotrophic Factor
9%
Synaptic Vesicle
9%
Diffusion Tensor Imaging
9%
Electroencephalography
9%
Meta-Analysis
9%
Randomized Controlled Trial
9%
Hypothermia
9%
Cerebral Hemorrhage
9%
Transverse Myelitis
9%
Myelitis
9%
Systemic Lupus Erythematosus
9%
Insulin Receptor
9%
Obstructive Sleep Apnea
9%
Interleukin 1
7%
Interleukin 6
6%
Necrosis
6%
Neuroprotective Agent
5%
Medicine and Dentistry
Brain Ischemia
52%
Parkinson's Disease
18%
Diabetes Mellitus
17%
Apoplexy
16%
Prognosis
15%
Sensitivity and Specificity
12%
Biological Marker
12%
Symptom
12%
Symptomatic Treatment
12%
Targeted Temperature Management
11%
Heart Arrest
11%
Maturity Onset Diabetes of the Young
10%
Atrial Fibrillation
10%
Antithrombotic
10%
Blood Clot Lysis
10%
National Institutes of Health Stroke Scale
10%
Disseminated Herpes Zoster
9%
Brain Infarction
9%
Transverse Myelitis
9%
Systematic Review
9%
Meta-Analysis
9%
Amyloid
9%
Tau
9%
Percutaneous Thrombectomy
9%
Heart Valve Bioprosthesis
9%
Prognostic Factor
9%
Procoagulant
9%
Warfarin
9%
Thrombectomy
9%
Valve Replacement
9%
Synuclein
9%
Ipilimumab
9%
Systemic Lupus Erythematosus
9%
Anticoagulant
9%
Nivolumab
9%
Non Small Cell Lung Cancer
9%
Myasthenia gravis
9%
Myositis
9%
Polyneuropathy
9%
Malignant Neoplasm
9%
Low and Middle Income Countries
9%
Cancer Control
9%
Cerebral Hemorrhage
7%
Cross-Validation
7%
Decision Making
7%
Pathognomonic
6%
Immune-Related Adverse Events
6%
Muscle Weakness
6%
Electromyography
6%
Dyspnea
6%
Pharmacology, Toxicology and Pharmaceutical Science
Brain Ischemia
57%
Prognosis
20%
Heart Arrest
18%
Parkinson's Disease
18%
Randomized Controlled Trial
11%
Atrial Fibrillation
10%
Symptom
10%
Somatomedin C
9%
Brain Derived Neurotrophic Factor
9%
Headache
9%
Armodafinil
9%
Modafinil
9%
Botulinum Toxin B
9%
Hypersalivation
9%
Insulin Receptor Substrate 1
9%
Brain Hemorrhage
9%
Botulinum Toxin
9%
Procoagulant
9%
Sleep Disordered Breathing
9%
Migraine
9%
Levetiracetam
9%
Warfarin
9%
Malignant Neoplasm
9%
Tissue Plasminogen Activator
8%
Botulinum Toxin A
8%
Cross-Validation
7%
Anticoagulant Agent
6%
Diabetes Mellitus
6%
Daytime Somnolence
5%
Neuroprotective Agent
5%